Marshall Wace LLP Invests $3.43 Million in NanoString Technologies Inc (NSTG)

Marshall Wace LLP acquired a new position in NanoString Technologies Inc (NASDAQ:NSTG) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 192,391 shares of the biotechnology company’s stock, valued at approximately $3,430,000.

Several other hedge funds have also bought and sold shares of the company. Alliancebernstein L.P. raised its position in shares of NanoString Technologies by 21.5% in the 3rd quarter. Alliancebernstein L.P. now owns 19,800 shares of the biotechnology company’s stock worth $353,000 after acquiring an additional 3,500 shares in the last quarter. Teachers Advisors LLC raised its position in shares of NanoString Technologies by 9.3% in the 3rd quarter. Teachers Advisors LLC now owns 51,574 shares of the biotechnology company’s stock worth $920,000 after acquiring an additional 4,399 shares in the last quarter. Cpwm LLC raised its position in shares of NanoString Technologies by 27.1% in the 3rd quarter. Cpwm LLC now owns 23,898 shares of the biotechnology company’s stock worth $426,000 after acquiring an additional 5,098 shares in the last quarter. MetLife Investment Advisors LLC raised its position in shares of NanoString Technologies by 55.2% in the 3rd quarter. MetLife Investment Advisors LLC now owns 17,579 shares of the biotechnology company’s stock worth $313,000 after acquiring an additional 6,249 shares in the last quarter. Finally, Metropolitan Life Insurance Co. NY bought a new stake in NanoString Technologies in the 2nd quarter valued at about $108,000. 88.99% of the stock is owned by hedge funds and other institutional investors.

In related news, SVP Mary Tedd Allen sold 26,895 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $17.60, for a total value of $473,352.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Nicholas Galakatos sold 85,823 shares of the company’s stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $15.99, for a total value of $1,372,309.77. The disclosure for this sale can be found here. 20.90% of the stock is currently owned by corporate insiders.

Shares of NanoString Technologies stock opened at $16.40 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 3.62 and a quick ratio of 3.22. NanoString Technologies Inc has a one year low of $5.87 and a one year high of $18.86.

NanoString Technologies (NASDAQ:NSTG) last issued its quarterly earnings data on Thursday, November 8th. The biotechnology company reported ($0.56) EPS for the quarter, topping analysts’ consensus estimates of ($0.57) by $0.01. NanoString Technologies had a negative return on equity of 206.80% and a negative net margin of 58.11%. The firm had revenue of $28.62 million during the quarter, compared to analyst estimates of $25.90 million. On average, equities research analysts anticipate that NanoString Technologies Inc will post -2.6 EPS for the current fiscal year.

A number of brokerages recently commented on NSTG. JPMorgan Chase & Co. boosted their target price on NanoString Technologies to $20.00 and gave the company an “overweight” rating in a research report on Thursday, September 13th. Morgan Stanley boosted their target price on NanoString Technologies from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 10th. ValuEngine raised NanoString Technologies from a “hold” rating to a “buy” rating in a research report on Thursday, August 30th. BidaskClub lowered NanoString Technologies from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 15th. Finally, Robert W. Baird boosted their target price on NanoString Technologies from $15.00 to $18.00 and gave the company an “outperform” rating in a research report on Tuesday, September 11th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $19.60.

COPYRIGHT VIOLATION NOTICE: “Marshall Wace LLP Invests $3.43 Million in NanoString Technologies Inc (NSTG)” was first posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.wkrb13.com/2018/12/16/marshall-wace-llp-invests-3-43-million-in-nanostring-technologies-inc-nstg.html.

About NanoString Technologies

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

See Also: Put Option

Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies Inc (NASDAQ:NSTG).

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply